Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration‐resistant prostate cancer - Concepedia

Concepedia

Publication | Open Access

Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration‐resistant prostate cancer

DOI Full Paper Access

47

Citations

36

References

2010

Year

Manpreet Chadha, Lili Tian, Terry Mashtare, Valencia Payne, C. Silliman, Ellis Levine, Michael K. Wong, Candace S. Johnson, Donald L. Trump

Abstract

High-dose, iv calcitriol at a dose of 74 microg weekly in combination with dexamethasone was well tolerated but failed to produce a clinical or PSA response in men with CRPC.

References

	Year	Citations

Page 1